Horizon Kinetics Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $169K | Sell |
13,188
-604
| -4% | -$7.69K | ﹤0.01% | 309 |
|
|
2025
Q4 | $124K | Sell |
13,792
-604
| -4% | -$8.31K | ﹤0.01% | 309 |
|
|
2025
Q3 | $249K | Buy |
14,396
+604
| +4% | +$7.44K | ﹤0.01% | 284 |
|
|
2025
Q2 | $129K | Sell |
13,792
-804
| -6% | -$6.6K | ﹤0.01% | 327 |
|
|
2025
Q1 | $104K | Buy |
14,596
+200
| +1% | +$2.02K | ﹤0.01% | 327 |
|
|
2024
Q4 | $168K | Buy |
14,396
+604
| +4% | +$9.43K | ﹤0.01% | 320 |
|
|
2024
Q3 | $283K | Sell |
13,792
-604
| -4% | -$13.9K | ﹤0.01% | 281 |
|
|
2024
Q2 | $322K | Hold |
14,396
| – | – | 0.01% | 248 |
|
|
2024
Q1 | $396K | Hold |
14,396
| – | – | 0.01% | 231 |
|
|
2023
Q4 | $439K | Sell |
14,396
-604
| -4% | -$17.4K | 0.01% | 217 |
|
|
2023
Q3 | $474K | Hold |
15,000
| – | – | 0.01% | 219 |
|
|
2023
Q2 | $612K | Hold |
15,000
| – | – | 0.01% | 200 |
|
|
2023
Q1 | $559K | Buy |
15,000
+5,000
| +50% | +$196K | 0.01% | 208 |
|
|
2022
Q4 | $349K | Hold |
10,000
| – | – | 0.01% | 241 |
|
|
2022
Q3 | $560K | Hold |
10,000
| – | – | 0.01% | 200 |
|
|
2022
Q2 | $518K | Hold |
10,000
| – | – | 0.01% | 210 |
|
|
2022
Q1 | $727K | Hold |
10,000
| – | – | 0.01% | 202 |
|
|
2021
Q4 | $1.18M | Hold |
10,000
| – | – | 0.03% | 167 |
|
|
2021
Q3 | $1.34M | Hold |
10,000
| – | – | 0.03% | 152 |
|
|
2021
Q2 | $1.62M | Hold |
10,000
| – | – | 0.03% | 145 |
|
|
2021
Q1 | $803K | Hold |
10,000
| – | – | 0.02% | 200 |
|
|
2020
Q4 | $544K | Hold |
10,000
| – | – | 0.02% | 228 |
|
|
2020
Q3 | $199K | Hold |
10,000
| – | – | 0.01% | 337 |
|
|
2020
Q2 | $210K | Buy |
+10,000
| New | +$170K | 0.01% | 338 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP